World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
57
Citations
11473
World Ranking
3580
National Ranking
1414

Gene G. Olinger publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Gene G. Olinger sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 118 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Gene G. Olinger D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Gene G. Olinger sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 57 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Gene G. Olinger is affiliated with Boston University in the United States and has focused their research primarily in the field of Medicine. Their work encompasses a broad range of topics within medicine, with significant contributions related to Infectious Diseases, Epidemiology, Molecular Biology, Public Health, Environmental and Occupational Health, and Agronomy and Crop Science.

Their research addresses multiple significant themes including Viral Infections and Outbreaks Research, SARS-CoV-2 and COVID-19 Research, Influenza Virus Research Studies, Bacillus and Francisella bacterial research, Viral gastroenteritis research and epidemiology, Animal Disease Management and Epidemiology, and Zoonotic diseases and public health.

Gene G. Olinger has published extensively, with notable papers including:

  • MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses, 2020, Science
  • Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses, 2021, mBio
  • Project IDentif.AI: Harnessing Artificial Intelligence to Rapidly Optimize Combination Therapy Development for Infectious Disease Intervention, 2020, Advanced Therapeutics
  • Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs, 2021, Antimicrobial Agents and Chemotherapy
  • Significance of High-Containment Biological Laboratories Performing Work During the COVID-19 Pandemic: Biosafety Level-3 and -4 Labs, 2021, Frontiers in Bioengineering and Biotechnology

Frequent publication venues for their work include:

  • Global Security Health Science and Policy
  • Antimicrobial Agents and Chemotherapy
  • Science
  • mBio
  • Advanced Therapeutics

The scientist has collaborated regularly with several coauthors, including Kenneth B. Yeh, Falgunee K. Parekh, Judith M. White, Elizabeth A. Nelson, and Lisa Evans DeWald. These collaborations have contributed to the multi-disciplinary nature of their research outputs and reflect engagement with a network of experts in related domains.

Best Publications

  • Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

    Xiangguo Qiu;Gary Wong;Jonathan Audet;Alexander Bello

  • Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection

    Julie Dyall;Christopher M. Coleman;Brit J. Hart;Thiagarajan Venkataraman

  • Delayed Treatment of Ebola Virus Infection with Plant-Derived Monoclonal Antibodies Provides Protection in Rhesus Macaques

    Gene Garrard Olinger;James Pettitt;Do Kim

  • Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysis

    Jason Kindrachuk;Britini Ork;Brit J. Hart;Steven Mazur

  • FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection

    Lisa M. Johansen;Jennifer M. Brannan;Sue E. Delos;Charles J. Shoemaker

  • Ebola Virus-Like Particle-Based Vaccine Protects Nonhuman Primates against Lethal Ebola Virus Challenge

    Kelly L. Warfield;Dana L. Swenson;Gene G. Olinger;Warren V. Kalina

  • Evaluation of candidate vaccine approaches for MERS-CoV

    Lingshu Wang;Wei Shi;M. Gordon Joyce;Kayvon Modjarrad

  • Therapeutic Intervention of Ebola Virus Infection in Rhesus Macaques with the MB-003 Monoclonal Antibody Cocktail

    James Pettitt;Larry Zeitlin;Do H. Kim

  • Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays.

    Brit J. Hart;Julie Dyall;Elena Postnikova;Huanying Zhou

  • Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant

    Larry Zeitlin;James Pettitt;Corinne Scully;Natasha Bohorova

  • CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates

    Nancy J Sullivan;Lisa Hensley;Clement Asiedu;Thomas W Geisbert

  • Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study

    Danielle V Clark;Danielle V Clark;Hannah Kibuuka;Monica Millard;Salim Wakabi

  • A screen of approved drugs and molecular probes identifies therapeutics with anti–Ebola virus activity

    Lisa M. Johansen;Lisa Evans DeWald;Charles J. Shoemaker;Benjamin G. Hoffstrom

  • Structures of protective antibodies reveal sites of vulnerability on Ebola virus

    Charles D. Murin;Marnie L. Fusco;Zachary A. Bornholdt;Xiangguo Qiu

  • Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies

    Julie Dyall;Robin Gross;Jason Kindrachuk;Reed F. Johnson

  • Gene-Specific Countermeasures against Ebola Virus Based on Antisense Phosphorodiamidate Morpholino Oligomers

    Kelly L Warfield;Dana L Swenson;Gene G Olinger;Donald K Nichols

  • Multiple Cationic Amphiphiles Induce a Niemann-Pick C Phenotype and Inhibit Ebola Virus Entry and Infection

    Charles J. Shoemaker;Kathryn L. Schornberg;Sue E. Delos;Corinne Scully

  • Comparison of the plaque assay and 50% tissue culture infectious dose assay as methods for measuring filovirus infectivity.

    Sophie J. Smither;Calli Lear-Rooney;Julia Biggins;Jamie Pettitt

  • Induction of Humoral and CD8+ T Cell Responses Are Required for Protection against Lethal Ebola Virus Infection

    Kelly L. Warfield;Gene Olinger;Emily M. Deal;Dana L. Swenson

  • Mannose-binding lectin binds to Ebola and Marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complement-mediated virus neutralization.

    Xin Ji;Gene G. Olinger;Sheena Aris;Ying Chen

  • Activation of Triggering Receptor Expressed on Myeloid Cells-1 on Human Neutrophils by Marburg and Ebola Viruses

    Mansour Mohamadzadeh;Sadie S. Coberley;Gene G. Olinger;Warren V. Kalina

Frequent Co-Authors

Lisa E. Hensley
Lisa E. Hensley National Institutes of Health
Peter B. Jahrling
Peter B. Jahrling National Institute of Allergy and Infectious Diseases
Sina Bavari
Sina Bavari United States Army Medical Research Institute of Infectious Diseases
Kelly L. Warfield
Kelly L. Warfield United States Department of the Army
Judith M. White
Judith M. White University of Virginia
John M. Dye
John M. Dye United States Army Medical Research Institute of Infectious Diseases
Gregory T. Spear
Gregory T. Spear Rush University Medical Center
Michael R. Holbrook
Michael R. Holbrook National Institutes of Health
Jens H. Kuhn
Jens H. Kuhn National Institutes of Health
Erica Ollmann Saphire
Erica Ollmann Saphire La Jolla Institute For Allergy & Immunology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various related fields in healthcare and biotechnology. For those interested in managing health data, exploring online health information management degree programs cahiim accredited can provide the necessary skills and credentials to enter this growing sector.

If you are looking for quicker certification options, consider shortest online medical billing and coding certificate programs that offer efficient pathways into administrative roles supporting medical environments. These programs are designed to quickly prepare students for industry certifications and entry-level jobs.

Besides microbiology, the healthcare field offers a wide range of flexible learning options. Exploring online healthcare degrees presents opportunities that blend science with clinical practice, allowing for diverse career trajectories without traditional campus constraints.

For those interested in public health, several mph online programs with easy admission requirements provide accessible routes to specialize further. These programs facilitate advancements in community health, epidemiology, and health policy, all of which complement a microbiology background well.

Best Scientists Citing Gene G. Olinger

Trending Scientists